Heart failure drug jardiance tested against standard care in 5,000 patients
NCT ID NCT07044700
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study looks at how well the drug Jardiance works for people with a certain type of heart failure (HFrEF) compared to usual treatments. About 5,000 adults in China will be followed to see if Jardiance reduces the risk of death from heart problems or hospital stays for heart failure. The goal is to provide real-world evidence on the drug's effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital; National Center for Cardiovascular Diseases
Beijing, 100037, China
Conditions
Explore the condition pages connected to this study.